Projects funded by the NCN
Genetic mechanisms of drug resisntance in breast cancer patients treated with 5-fluorouracil, doxorubicine and cyclophosphamide.
2012/07/N/NZ5/00026
Keywords:
drug resisntance 5-fluorouracil doxorubicine cyclophosphamide breast cancer
Descriptors:
- NZ5_1: Etiology of human diseases
- NZ5_7: Human disease treatment
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 4 - announced on 2012-09-15
Amount awarded: 150 000 PLN
Project start date (Y-m-d): 2013-07-08
Project end date (Y-m-d): 2017-07-07
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (2)
- Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsAuthors:Tęcza K, Pamula-Piłat J, Łanuszewska J, Grzybowska E.Academic press:Oncotarget (rok: 2016, tom: 7(41), strony: 66790-66808), Wydawca: Impact Journals, LLCStatus:PublishedDOI:10.18632/oncotarget.11053 - link to the publication
- Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Authors:Tecza K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D, Grzybowska E.Academic press:Oncotarget (rok: 2018, tom: 9(10), strony: 9114-9136), Wydawca: Impact Journals, LLCStatus:PublishedDOI:10.18632/oncotarget.24148 - link to the publication